25 Feb 2022
Janssen Inc. v. Teva Canada Ltd.
The court awarded costs to Janssen Inc. and Janssen Pharmaceutica in their patent infringement case against Teva Canada Ltd. The plaintiffs claimed $3,699,540.67 in costs, but the court found their fees and disbursements to be excessive. The court reduced the legal fees to $2,619,607.46 and the disbursements to $1,079,933.21. The total costs awarded were $2,697,671.79, with post-judgment interest at 2 percent.
